American Association For Justice News
AAJ Statement on National Law DayMay 1, 2012
Washington, DC -The following is a statement from American Association for Justice (AAJ) President Gary M. Paul in honor of National Law Day:
AAJ Statement on the Domestic Fuels Protection ActApril 19, 2012
Washington, DC - The following is a statement from American Association for Justice (AAJ) President Gary M. Paul in response to the "The Domestic Fuels Protection Act of 2012," H.R. 4345:
Congressional Proposal Would Expand Generic Drug Manufacturers' Duty to WarnApril 18, 2012
Washington, DC-Today Senator Patrick Leahy (D-VT) and six co-sponsors introduced the "Patient Safety and Generic Labeling Improvement Act of 2012" (S. 2295), amending U.S. Food and Drug Administration (FDA) regulations to allow manufacturers of generic drugs to initiate labeling updates. A companion bill, "Patient Safety and Drug Labeling Act," (H.R. 4384) was introduced in the U.S. House of Representatives by Reps. Bruce Braley (D-IA) and Chris Van Hollen (D-MD).
ALEC Bills Eliminate Accountability, Endanger AmericansApril 12, 2012
Washington, DC- Florida Special Prosecutor Angela Corey announced yesterday that the State of Florida has taken the first step to achieving justice for Trayvon Martin and his family by filing criminal charges against George Zimmerman.
GAO Recommends Improvements to the Medicare Repayment BureaucracyApril 4, 2012
Washington, DC-Today, the U.S. Government Accountability Office (GAO) released a report - requested by Ranking Member of the Ways and Means Health Subcommittee Rep. Pete Stark (D-CA) - analyzing the inefficiencies of the Medicare Secondary Payer system (MSP).
AAJ Statement on House Passage of H.R. 5March 22, 2012
Washington, DC-The following is a statement from American Association for Justice (AAJ) President Gary M. Paul in response to the House passage of "medical liability reform bill" H.R. 5:
Report: Medical Malpractice Insurers More Profitable Than Top Fortune 500 CompaniesMarch 20, 2012
Washington, DC-As the U.S. House of Representatives prepares to vote on an extreme medical liability bill (H.R. 5), a new report reveals that the average profit margin for the top 10 medical malpractice insurers is twice as high as 50 of the most profitable Fortune 500 companies.
March 9, 2012
Washington, DC-The U.S. Food and Drug Administration (FDA) should require generic drug manufacturers to update their warning labels to protect patients from previously unknown side-effects, according to the American Association for Justice.
AAJ Calls for Transparency of Medical Industry PaymentsFebruary 16, 2012
Washington, DC-Establishing a reporting requirement that creates transparency of payments from drug and device manufacturers to doctors and hospitals will increase patient safety by reducing conflicts of interest, according to comments submitted today by the American Association for Justice (AAJ) to the Centers for Medicare and Medicaid Services (CMS).
AAJ Response to Carlyle Dropping Forced Arbitration Clause in IPOFebruary 3, 2012
Washington, DC-The Carlyle Group today announced that they are withdrawing the forced arbitration clause that was included in its proposed IPO filing to the U.S. Securities and Exchange Commission, in response to pressure from shareholder rights advocates and lawmakers. The following is a statement from American Association for Justice President Gary M. Paul: